On this episode of EAUTV, Prof. Morgan Roupret and Prof. Ashish Kamat tackle a full day of bladder cancer at EAU22. Their conversation ranges from the use of targeted drug use in the treatment of metastatic bladder cancer, facilitating patient-doctor transparency in late-stage high-risk bladder cancer, and how to judge the outcomes of conflicting studies. You can view the full conversation here.
